Form 4: Clene Director Jonathon Gay Granted Stock Options

Clene Inc. Director Jonathon Gay was granted 2,438 stock options at an exercise price of $7.30 per share, vesting immediately.

Summary

• Jonathon Gay, a Director of Clene Inc. (CLNN), was granted stock options.
• The transaction date for the grant was November 13, 2025.
• A total of 2,438 shares of common stock were granted as stock options.
• The exercise price for these options is $7.30 per share.
• The options were granted under the Clene Inc. Amended 2020 Stock Plan.
• These options vest immediately upon grant.
• The expiration date for these stock options is November 12, 2035.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. It's a routine compensation event for a director, which generally aligns management interests with shareholders, but does not indicate specific operational or financial performance.

Positives

• The stock options vest immediately upon grant, providing immediate equity interest.
• The grant aligns the director's financial interests with those of the shareholders.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future performance, but rather reports a specific insider transaction.

Industry Context

The grant of stock options to a director is a common practice in the biotechnology and pharmaceutical industries, used to incentivize leadership and align their interests with long-term company performance and shareholder value. This is a standard compensation mechanism.

Comparison to Industry Standards

• Granting stock options to directors is a widely accepted compensation practice across various industries, including biotech, to attract and retain talent and align interests.
• Immediate vesting, while not universal, is sometimes used for director grants to reflect their ongoing strategic oversight rather than performance-based milestones typical for executive grants.

Corporate Governance

Related Party Transactions

• The grant of stock options to Jonathon Gay, a Director of Clene Inc., constitutes a related party transaction as it involves compensation provided by the company to a member of its board.

Stakeholder Impact

• Shareholders: The grant aligns the director's interests with shareholder value creation, as the options gain value if the stock price increases above the exercise price.
• Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

• Jonathon Gay may choose to exercise these options at any time before their expiration date of November 12, 2035.

Key Dates

Keywords

Clene Inc., CLNN, Jonathon Gay, Stock Option, Insider Transaction, Director Compensation, Equity Grant, Form 4